Free CME from PeerView


Oncology CME

Aditya Bardia, MD, MPH
Credits: 1.0 CME
Medical Learning Institute, Inc.
Expanding Treatment Options in ER+/HER2- Breast Cancer: Expert Perspectives on the Rapidly Emerging Role of SERDs, SERMs, and SERCAs, and the Practical Considerations of Leveraging Established and Innovative Therapies
Erika Hamilton, MD
January 19, 2022
Credits: 0.25 CME / MOC
Medical Learning Institute, Inc.
Practice Points in TGCT: Updates on Safe Use of Novel Systemic Options
William D. Tap, MD
January 13, 2022
Melissa Hohos, RN, BSN, OCN
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Optimally Sequencing Modern TKIs in GIST: Expert Perspectives From an Interprofessional Sarcoma Team
Michael Heinrich, MD
January 13, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
Upstream and Downstream Targeting of the Complement Pathway to Manage PNH: Current and Emerging Inhibitors
Carlos M. de Castro, MD
December 31, 2021
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Advances in Pediatric Growth Hormone Therapy: Visualizing the Impact on Individualized Care
Bradley S. Miller, MD, PhD
December 29, 2021
Credits: 2 CME
Penn State College of Medicine
Achieving Innovation in CLL Care: Evidence-Informed Choices With Targeted Options and Next Steps in Disease Management
John G. Gribben, MD, DSc, FRCP, FRCPath, FMedSci
December 29, 2021
Credits: 1 CME
Medical Learning Institute, Inc.
Carrying Through in Advanced/Metastatic Urothelial Carcinoma: Expert Perspectives on Recent Practice‐Changing Data and the Practicalities of Individualizing and Continuing Care With Novel Immunotherapy Maintenance Strategies
Professor Thomas Powles, MBBS, MRCP, MD
December 28, 2021
Credits: 0.5 CME / MOC / CC / NCPD / CPE
Medical Learning Institute, Inc.
New Advances and Opportunities for Improvement in HR+/HER2- Early Breast Cancer: Practical Strategies for Optimal Clinical Integration of Adjuvant CDK4 and 6 Inhibitor Therapy
Sara M. Tolaney, MD, MPH
December 27, 2021
Jacqueline Barrientos, MD, MS
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Customizing Care in CLL With BTK Inhibitors: Evidence and Applications for Therapy Selection, Sequencing, and Safety Management
John C. Byrd, MD
December 10, 2021
Javier Cortés, MD, PhD
Credits: 1.5 CME / MOC / NCPD
Medical Learning Institute, Inc.
Personalizing Treatment Decisions in HER2-Altered Breast Cancer: Strategies for Improving Equity and Patient Outcomes Through Individualized Targeted Therapy Selection, Team-Based Care, and Shared Decision-Making
Joyce O’Shaughnessy, MD
December 10, 2021
Noa Biran, MD
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
A Is for Antibody in Multiple Myeloma: Practical Insights and Patient Voices Along the Therapeutic Journey
Suzanne Lentzsch, MD, PhD
December 10, 2021
Caitlin Costello, MD
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Unlocking the Benefits of CAR-T Therapy in Hematologic Malignancies: Latest Evidence and Practical Considerations for Delivering State-of-the-Art Care
Caron Jacobson, MD
December 10, 2021
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Taking the Turn to Treatment Innovation in DLBCL: Real-World Insight on Integrating Antibodies and Cellular Therapy Into Patient Care
Grzegorz (Greg) Nowakowski, MD
December 10, 2021
Credits: 1.5 CME
Medical Learning Institute, Inc.
A Better Blend for Follicular Lymphoma: How Targeted, Epigenetic, and Immune Therapies Are Changing Patient Care
Nathan H. Fowler, MD
December 10, 2021
Credits: 2 CME / MOC
Medical Learning Institute, Inc.
Seizing Opportunity in AML: How to Realize the Potential of Novel Therapeutics in Diverse Patient Populations
Naval Daver, MD
December 9, 2021
Pedro C. Barata, MD, MSc
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Personalizing and Advancing Modern Treatment Approaches to Prostate Cancer
Pedro C. Barata, MD, MSc
November 30, 2021
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Breaking Down the Evidence in Bladder Cancer: Expert Perspectives and Practical Strategies on Immune, Targeted, and Antibody-Based Therapies
Petros Grivas, MD, PhD
November 30, 2021
Credits: 0.5 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Changing Tides in Advanced Endometrial Cancer: A Visual Exploration of Current and Emerging Strategies to Maximize the Potential of Cancer Immunotherapies
Jubilee Brown, MD
November 29, 2021
Manmeet Ahluwalia, MD, MBA
Credits: 1 CME
Medical Learning Institute, Inc.
A New Wave of Progress in Glioblastoma: Expert Guidance on Delivering Modern Personalized Care With Tumor Treating Fields and Novel Systemic Approaches
Steven Brem, MD
November 20, 2021
Credits: 0.5 CME / MOC
Medical Learning Institute, Inc.
Visualizing Progress With BTK Inhibitors: An Animated Journey Through the Mechanisms of Covalent and Noncovalent Options
Nirav Shah, MD, MS
November 18, 2021
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Adjuvant EGFR-Targeted Therapy as a Game Changer: How to Implement New Standards of Care in Multimodal Management of Stage I-III EGFR-Mutated NSCLC
David R. Jones, MD
November 18, 2021
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Translating Science, Transforming Practice, and Making Headway Toward Better Outcomes in SCLC: Immunotherapy Has Changed the Game, but Where Do We Go Next?
Jonathan W. Goldman, MD
November 17, 2021
Credits: 1 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Improving the Detection and Management of Cardiac Immune-Related Adverse Events in Patients With Cancer Is a Must: Are You Prepared?
Javid Moslehi, MD
November 14, 2021
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Harmonizing HCC Care With a Multidisciplinary Ensemble: Guidance for the Era of Novel Locoregional, Multimodal, and Systemic Strategies
Amit Singal, MD, MS
November 13, 2021
Credits: 1 CME / MOC / CC / NCPD / CPE
Medical Learning Institute, Inc.
Raising the Bar in HR+/HER2- Early Breast Cancer: Multidisciplinary Strategies for Integrating the CDK4 and 6 Inhibitors
Joyce O’Shaughnessy, MD
November 7, 2021
Credits: 1 CME
Medical Learning Institute, Inc.
Selecting and Sequencing Targeted and Immunotherapy Regimens for RCC: How Will the Latest Evidence Impact Treatment Decisions for My Patients?
Sumanta Kumar Pal, MD, FASCO
November 3, 2021
Credits: 1 CME
Medical Learning Institute, Inc.
Immunotherapy at the Cutting Edge in Resectable Esophageal/GEJ Cancer: Preparing Thoracic Surgeons and the Broader Multidisciplinary Team to Navigate Changing Standards of Care
Ronan J. Kelly, MD, MBA
November 3, 2021
Credits: 0.5 CME / MOC
Medical Learning Institute, Inc.
Overcoming the Challenges of Diverse TGCT Presentations: Diagnostic and Treatment Principles for the Multidisciplinary Team
October 28, 2021
Credits: 1 CME / MOC / CC
Medical Learning Institute, Inc.
Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLC: Refining and Expanding Best Practices in Advanced and Early-Stage Disease Settings
Lynette M. Sholl, MD
October 28, 2021
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Maintaining Vigilance to Mitigate Cancer Immunotherapy-Related Toxicities in the Emergency Department: Be Aware, Stay Alert, and Change Your Practice
Christopher Baugh, MD, MBA, Mark M. Awad, MD, PhD
October 24, 2021

Pages

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView